Lewis School of Health Sciences Newsletter: November 2021

Message From the Founding Dean

The fall semester may be winding down, but the Lewis School continues to run at full steam. Our students, busy working toward board certifications, are mentored by faculty who value not only pedagogy, but also innovation in their own scholarship. In this newsletter, you can read about a recent example of such a faculty member, as well as another distinguished practitioner who returned to Clarkson after serving in state and national government healthcare systems. We also invite you to join our bioethics program in celebrating its 20th anniversary through a series of webinars. Please stay healthy and safe, and enjoy the fall season.

— Lennart Johns, Founding Dean of Health Sciences

Celebrating Two Decades

Our bioethics program continues its 20th anniversary celebration with Pioneering Bioethics: An Anniversary Celebration — a free, monthly virtual lecture series. October’s event commemorated the life and legacy of Robert M. Veatch, a pioneer in the field of bioethics and a founding faculty member of the bioethics program.

Welcome Back

We are very excited to have Dana McGuire Olzenak MBA’02 return to Clarkson as a clinical associate professor of physical therapy. She was a director in the Physical Therapy Department before moving on to other appointments, including at the CDC. Most recently, she led St. Lawrence County’s pandemic response as the public health director.

Making Our Mark

You don’t have to be the biggest to pack the strongest punch. At least, that’s what recent rankings confirm. Clarkson has been listed in the top 10% of all schools in the nation (College Factual), ranked as a tier one university (U.S. News & World Report) and placed on the U.S. News Best Value Schools list, alongside Princeton, Yale and Harvard.

Mending Bones

At any time, a novel device that helps heal broken bones is a real asset. But when the supply chain is under unprecedented strain, anything that adds value is a godsend. Professor Laurel Kuxhaus helped develop such a device — an adjustable-length intramedullary nail — that is making its way through the FDA approval process.